MEI Pharma, Inc. Common Stock (LITS) Stock Analysis

MEI Pharma, Inc. Common Stock (LITS) is a publicly traded company in the NONE sector. It trades at $0.82, carries a market capitalization of $34.37M. This page summarizes the public market data, fundamentals, and frequently asked questions for LITS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: NONE - NONE

Exchange: NASDAQ

Key Metrics

Market Sentiment

MEI Pharma, Inc. Common Stock currently has a Bullish sentiment score of 0.21.

About MEI Pharma, Inc. Common Stock

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company is headquartered in San Diego, California.

GNG Research Analysis

GNG Research scores MEI Pharma, Inc. Common Stock (LITS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for LITS.

Frequently Asked Questions

Does LITS pay dividends?

MEI Pharma, Inc. Common Stock (LITS) does not currently pay a regular dividend.

What is LITS's market cap?

MEI Pharma, Inc. Common Stock (LITS) has a market capitalization of $34.37M with a current stock price of $0.82.